Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Hum Pathol. 2013 Oct 19;45(3):456–463. doi: 10.1016/j.humpath.2013.10.008

Table 1.

Expression of SOX9 in benign pancreatic tissue, pancreatic intraepithelial neoplasia and cystic neoplasms of the pancreas

Type of tissue Number of cases Negative (%) Focal staining (%) Diffuse staining (%) P valueb
Benign pancreatic tissue 146
 Normal 109 0 (0) 0 (0) 109 (100)
 Chronic pancreatitis 37 0 (0) 0 (0) 37 (100) 1.00
Pancreatic intraepithelial neoplasia
 Grade 1 18 0 (0) 0 (0) 18 (100) 1.00
 Grade 2 21 0 (0) 6 (28.6) 15 (71.4) <0.01
 Grade 3 8 0 (0) 2 (25.0) 6 (75.0) 0.004
Intraductal Papillary Mucinous Neoplasm 21
 Low Grade Dysplasia 13a 0 (0) 3 (23.1) 10 (76.9) 0.001
 High Grade Dysplasia 11 0 (0) 2 (18.2) 11 (81.8) 0.01
Mucinous cystic neoplasm 14
 Low Grade Dysplasia 14a 0 (0) 0 (0) 14 (100) 1.00
 High Grade Dysplasia 3 0 (0) 0 (0) 3 (100) 1.00
Serous cystadenoma 10 0 (0) 0 (0) 10 (100) 1.00
a

Including three patients with both low-grade and high-grade dysplasia;

b

P values compared to normal pancreas